FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.

Details

Language :

English

ISSN :

0732183X

Volume :

41

Issue :

25

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

170897490

Full Text :

https://doi.org/10.1200/JCO.22.01420